| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
175,936 |
13,116 |
$15.40M |
| 90945 |
|
10,105 |
399 |
$847K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
285 |
24 |
$16K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
49,408 |
4,142 |
$15K |
| A4657 |
Syringe, with or without needle, each |
13,655 |
7,032 |
$11K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
81,171 |
5,195 |
$11K |
| J0604 |
Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
2,055 |
1,057 |
$4K |
| J1756 |
Injection, iron sucrose, 1 mg |
17,337 |
5,057 |
$4K |
| G0008 |
Administration of influenza virus vaccine |
376 |
358 |
$524.89 |
| 90662 |
|
115 |
115 |
$73.40 |
| 85048 |
|
5,149 |
4,798 |
$16.54 |
| 83550 |
|
4,113 |
3,955 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
2,652 |
2,067 |
$0.00 |
| 82607 |
|
317 |
317 |
$0.00 |
| 82728 |
|
5,062 |
4,814 |
$0.00 |
| 90747 |
|
21 |
21 |
$0.00 |
| 82746 |
|
338 |
336 |
$0.00 |
| 90674 |
|
92 |
91 |
$0.00 |
| G0010 |
Administration of hepatitis b vaccine |
13 |
13 |
$0.00 |
| 83540 |
|
5,015 |
4,758 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
9,505 |
718 |
$0.00 |
| 85041 |
|
5,148 |
4,800 |
$0.00 |
| J0887 |
Injection, epoetin beta, 1 microgram, (for esrd on dialysis) |
1,348 |
836 |
$0.00 |
| 83970 |
|
5,586 |
5,246 |
$0.00 |
| 82108 |
|
1,459 |
1,405 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,358 |
191 |
$0.00 |
| 85045 |
|
83 |
60 |
$0.00 |
| 0013A |
|
17 |
17 |
$0.00 |